Amarin Corp Plc (AMRN)

[ziploc_1]

QUOTE..." The preliminary results suggest that the trial may not have meet its primary endpoint, which was an improvement in blood flow in the brain"

Obviously the Brave trial did not meet statistical significance, but it still may have trended positively...With the small number of patients in the study, no one really expected statistical significance anyway.